Balyasny Asset Management’s Amsurg Corp AMSG Stock Holding History

Balyasny Asset Management’s Portfolio AMSG Stock Details AMSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-822,528	Closed	-$55.2M	–	1590
2016 Q3	$55.2M	Buy	822,528 +443,446	+117%	+$31M	0.32%	89
2016 Q2	$29.4M	Buy	+379,082	New	+$29.3M	0.19%	144
2016 Q1	–	Sell	-91,264	Closed	-$6.94M	–	1706
2015 Q4	$6.94M	Buy	91,264 +76,064	+500%	+$6.02M	0.05%	436
2015 Q3	$1.18M	Buy	+15,200	New	+$1.17M	0.01%	720
2014 Q3	–	Sell	-238,174	Closed	-$10.9M	–	942
2014 Q2	$10.9M	Buy	+238,174	New	+$10.9M	0.12%	216

Other funds holding AMSG

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $5.64B AUM

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Balyasny Asset Management's AMSG Position: Q4 2016 in Review

Balyasny Asset Management sold out of Amsurg Corp (AMSG) in Q4 2016, closing a stake of 822,528 shares — an estimated $55.2M sold.

Balyasny Asset Management first reported a position in AMSG in Q2 2014 and held it in 5 quarters. The position peaked at $55.2M in Q3 2016. 7 funds tracked by Wall St. Rank hold AMSG as of Q4 2016.

Balyasny Asset Management reported no remaining Amsurg Corp position as of Q4 2016 after selling out during the quarter.
Balyasny Asset Management sold 822,528 Amsurg Corp shares in Q4 2016, an estimated $55.2M.
Balyasny Asset Management first reported a position in Amsurg Corp in Q2 2014 and held it in 5 quarters.
Balyasny Asset Management's Amsurg Corp position peaked at $55.2M in Q3 2016.
7 funds tracked by Wall St. Rank held Amsurg Corp as of Q4 2016.

Based on Balyasny Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.